GE HealthCare Technologies Inc. (GEHC)
Data as of , from SEC Form 4 filings.
See up to 3 months of GEHC. The 7-day demo opens the 1M and 3M ranges and puts GEHC on your watchlist.
Start 7-day demoLatest GEHC insider trades
About GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
- CHICAGO, IL
- 54,000
- 2022
- XNAS
GEHC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 106,973 | |
| Tax withholding / forfeiture | 20 | 33,619 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GEHC insider transactions (Form 4)
4173 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock, par value $0.01 per share | 62,256 footnote F1,F2 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 12,840 footnote F2,F3 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 31,877 | $0.00 footnote F4 | - | ||
| ||||||
| Philip Rackliffe - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 798 footnote F1 | $70.56 | $56K | |
| ||||||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 718 footnote F1 | $70.56 | $51K | ||
| ||||||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 112 footnote F1 | $70.56 | $8K | ||
| ||||||
| Taha Kass-Hout - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,502 footnote F1 | $70.56 | $106K | |
| ||||||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,480 footnote F1 | $70.56 | $104K | ||
| ||||||
| Adam Y. Holton - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 673 footnote F1 | $70.56 | $47K | |
| ||||||
| Catherine Estrampes - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 508 footnote F1 | $70.56 | $36K | |
| ||||||
| Peter J. Arduini - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 6,303 footnote F1 | $70.56 | $445K | |
| ||||||
| Philip Rackliffe - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 290 footnote F1 | $71.23 | $21K | |
| Philip Rackliffe - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 226 footnote F1 | $71.23 | $16K | |
| Philip Rackliffe - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 340 footnote F1 | $71.23 | $24K | |
| ||||||
| Taha Kass-Hout - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,644 footnote F1 | $71.23 | $117K | |
| Taha Kass-Hout - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,296 footnote F1 | $71.23 | $92K | |
| ||||||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,751 footnote F1 | $71.23 | $125K | ||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,380 footnote F1 | $71.23 | $98K | ||
| ||||||
| Adam Y. Holton - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 659 footnote F1 | $71.23 | $47K | |
| ||||||
| Jeannette Bankes - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,064 footnote F1 | $71.23 | $76K | |
| ||||||
| Peter J. Arduini - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 6,043 footnote F1 | $71.23 | $430K | |
| Peter J. Arduini - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 5,472 footnote F1 | $71.23 | $390K | |
| ||||||
| Adam Y. Holton - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,360 footnote F1 | $73.69 | $100K | |
| ||||||
| Kevin Lobo - Director | Open-market purchase | Common Stock, par value $0.01 per share | 10,000 | $64.18 | $642K | |
| Philip Rackliffe - Officer | Grant or award | Common Stock, par value $0.01 per share | 16,458 footnote F1,F2 | $0.00 | - | |
| ||||||
| Jeannette Bankes - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 5,535 footnote F1 | $62.67 | $347K | |
| ||||||
| Rodney F. Hochman - Director | Open-market purchase | Common Stock, par value $0.01 per share | 1,618 | $62.03 | $100K | |
| Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | ||
| Open-market purchase | Common Stock, par value $0.01 per share | 1,000 | $63.01 footnote F3 | $63K | ||
| ||||||
| Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 4,157 footnote F2,F3 | $0.00 | - | ||
| ||||||
| Rodney F. Hochman - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | |
| Rodney F. Hochman - Director | Grant or award | Common Stock, par value $0.01 per share | 2,689 footnote F2,F3 | $0.00 | - | |
| ||||||
| Catherine A. Lesjak - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | |
| ||||||
| Kevin Lobo - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 2,282 footnote F2,F3 | $0.00 | - | ||
| ||||||
| William J. Stromberg - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 footnote F1,F2 | $0.00 | - | |
| ||||||
| Open-market purchase | Common Stock, par value $0.01 per share | 80,805 | $61.88 footnote F1 | $5.00M | ||
| ||||||
| William J. Stromberg - Director | Open-market purchase | Common Stock, par value $0.01 per share | 1,000 | $61.69 | $62K | |
| James Saccaro - Officer | Open-market purchase | Common Stock, par value $0.01 per share | 3,310 | $60.60 footnote F1 | $201K | |
| ||||||
Stock trades in GEHC disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
GEHC insider trading FAQ
What is the latest insider trade for GEHC?
GE HealthCare Technologies Inc. (GEHC) had 16 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for GEHC runs to 73 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GEHC stock?
No insider purchases of GEHC were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling GEHC stock?
No insider sales of GEHC were filed in the last 90 days. 2 sales are on record for this company.
Where can I see GEHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GEHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William K. Grogan view on EDGAR
- - Philip Rackliffe view on EDGAR
- - Kevin Michael O'Neill view on EDGAR
- - George A. Newcomb view on EDGAR
- - Taha Kass-Hout view on EDGAR
- - Frank R. Jimenez view on EDGAR
- - Adam Y. Holton view on EDGAR
- - Catherine Estrampes view on EDGAR
- - Peter J. Arduini view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where GEHC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GEHC with a 7-day demo
- GEHC on your watchlist
- Every GEHC Form 4 filing on record
- Up to 3 months of GEHC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive